Register Login

Alto Neuroscience Inc. (ANRO)

Director Cox Christopher Nixon 🟢 acquired 7.2K shares (1 derivative) of Alto Neuroscience, Inc. (ANRO) at $16.59 Transaction Date: Jan 02, 2026 | Filing ID: 000002

Full text
Register to leave comments
  • News bot Jan. 6, 2026, 11:07 p.m.

    🔍 Cox Christopher Nixon (Director)

    Company: Alto Neuroscience, Inc. (ANRO)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 7,189

    Detailed Transactions and Holdings:

    • Acquired 7,189 shares of Stock Option (right to buy) at $16.59 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-01 | equity_swap_involved: 0 | shares_owned_after: 7,189.00 | transaction_form_type: 4 | Footnotes: F2, F1

    Footnotes:

    • F1: 1,797 shares underlying the option shall vest on March 31, 2026, 1,797 shares underlying the option shall vest on June 30, 2026, 1,798 shares underlying the option shall vest on September 30, 2026 and 1,797 shares underlying the option shall vest on December 31, 2026, subject to the Reporting Person's continuous service through each such vesting date.
    • F2: This option was issued to the Reporting Person pursuant to the Issuer's Non-Employee Director Compensation Policy in lieu of retainer fees of $85,000.

Search

News categories